NZ scientists make breakthrough in Facial Eczema research
A significant breakthrough in understanding facial eczema (FE) in livestock brings New Zealand closer to reducing the disease’s devastating impact on farmers, animals, and rural communities.
FACIAL ECZEMA (FE) is a disease with a huge economic impact in the warm humid areas of New Zealand, points out Robin Pharmaceuticals, maker of the FiltaBac treatment for the disease.
FE affects dairy and beef cattle of all ages, younger animals being more susceptible, sheep and red deer also being affected by Pithomyces chartarum fungal spores.
Prevention is always paramount in managing productivity however the problem grows when physical (clinical) symptoms of FE appear: the extreme damaging effects from the Sporidesmin toxin causes liver damage, which can then lead to photosensitisation of the white or non-pigmented skin on cattle and sheep.
Photosensitivity occurs because the FE damaged liver cannot remove wastes and a breakdown product of grass pigments (chlorophyll) accumulates. The non-pigmented or thin skin thickens, cracks, peels and causes pain. Cows are restless at milking time, seek shade and lick their udders.
In some cases the teats and udder become so severely damaged it is impossible to milk the affected quarter of the cow.
FiltaBac Cream was formulated by Robin Pharmaceuticals Ltd in 1971, has been registered with the Animal Remedies Board since then, and has proved effective in alleviating the extreme skin damaging effects of facial eczema.
Robin Pharmaceuticals chief executive Samantha Sinclair attributes FiltaBac cream’s effectiveness to its sun and light blocking action achieved by the high percentage of non-absorbed, inert mineral compounds titanium dioxide and zinc oxide in the cream. These two sun-blockers, combined with the anti-bacterial qualities of the cetrimide and benzalkonium chloride, calm the skin and promote wound healing, Sinclair says.
“What also happens when FiltaBac is applied onto the damaged skin area is that there is an almost immediate soothing, pain relief reaction,” she says.
“This allows for the affected quarter(s) to be protected like a second skin covering and at the following milking, after cleansing the area, the affected quarters could be milked. Following this method does not produce milk grades.
“The real benefit is the barrier cover FiltaBac Cream provides, simulating the properties of undamaged skin, allowing for moist wound healing, preserving the new skin cells, allowing them to breathe and maintain correct moisture levels.”
www.aniwell-nz.com
Federated Farmers president Wayne Langford says the 2025 Fieldays has been one of more positive he has attended.
A fundraiser dinner held in conjunction with Fieldays raised over $300,000 for the Rural Support Trust.
Recent results from its 2024 financial year has seen global farm machinery player John Deere record a significant slump in the profits of its agricultural division over the last year, with a 64% drop in the last quarter of the year, compared to that of 2023.
An agribusiness, helping to turn a long-standing animal welfare and waste issue into a high-value protein stream for the dairy and red meat sector, has picked up a top innovation award at Fieldays.
The Fieldays Innovation Award winners have been announced with Auckland’s Ruminant Biotech taking out the Prototype Award.
Following twelve years of litigation, a conclusion could be in sight of Waikato’s controversial Plan Change 1 (PC1).
OPINION: Last week, Greenpeace lit up Fonterra's Auckland headquarters with 'messages from the common people' - that the sector is…
OPINION: Once upon a time the Fieldays were for real farmers, salt of the earth people who thrived on hard…